Sindlev Rene 13D/13G Filings for Renovaro Biosciences Inc. (RENB)

Sindlev Rene 13D and 13G filings for Renovaro Biosciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-16
3:03 pm
Purchase
2024-02-1313DRenovaro Biosciences Inc.
RENB
Sindlev Rene14,945,971
10.280%
14,945,971increase
(New Position)
Filing